Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years

Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is a staple in the portfolios of conservative long-term investors and seniors alike.

For decades, J&J, as the company is more commonly known, has found ways to grow sales, boost its profitability on an adjusted basis, and hand out more cash to investors. In fact, Johnson & Johnson is working on a 55-year streak of increasing its annual dividend. You can count on two hands how many publicly traded companies currently boast a longer streak, and J&J's 2.6% yield is nicely ahead of the average yield of S&P 500 stocks. Add the icing on the cake, which is very low volatility, and we have a stock that has the potential to make money for investors in practically any economic environment.

Image source: Getty Images.

Continue reading

Source: Fool.com